Selenium Donor Inhibited Hepatitis B Virus Associated Hepatotoxicity via the Apoptosis and Ferroptosis Pathways.

IF 2.6 4区 医学 Q3 CELL BIOLOGY
Jingdong Shi, Zhen Liu, Weina Li, Di Wang
{"title":"Selenium Donor Inhibited Hepatitis B Virus Associated Hepatotoxicity via the Apoptosis and Ferroptosis Pathways.","authors":"Jingdong Shi,&nbsp;Zhen Liu,&nbsp;Weina Li,&nbsp;Di Wang","doi":"10.1155/2023/6681065","DOIUrl":null,"url":null,"abstract":"<p><strong>Methods: </strong>The serum selenium level was determined in 45 patients with HBV-positive HCC (HBV<sup>+</sup>-HCC group), 45 patients with chronic hepatitis B virus infection (CHB group), and 45 healthy cases (HC group). The sodium selenite (Na<sub>2</sub>SeO<sub>3</sub>)-treated HepG2.2.15 cells were used to observe the regulatory role of selenium on HBV replication. D-GalN/erastin-added HL7702 was used to determine the regulatory roles of Na<sub>2</sub>SeO<sub>3</sub> on hepatotoxicity or hepatocyte ferroptosis. The wild-type (WT) C57BL/6 mice and HBx-Tg mice were received lipopolysaccharide (LPS)/D-GalN, together with or without Na<sub>2</sub>SeO<sub>3</sub> administration for indicated period. Following euthanasia, the blood and liver tissue samples were collected, and specific markers were evaluated subsequently.</p><p><strong>Results: </strong>The serum selenium level was downregulated in patients with HBV-positive HCC (HBV<sup>+</sup>-HCC group) (57.2 ± 22.5 <i>μ</i>g/L vs. 91.8 ± 43.9 <i>μ</i>g/L, <i>P</i> < 0.001), and its higher level could provide a better prognosis in these patients. The treatment using Na<sub>2</sub>SeO<sub>3</sub>, a selenium donor, at high concentration (5 <i>μ</i>M), suppressed the HBV replication by about 50% in HepG2.2.15 cells (<i>P</i> < 0.001), through promoting apoptotic cell death and inhibiting cellular inhibitor of apoptosis proteins (cIAPs). In addition, low-dose (500 nM) Na<sub>2</sub>SeO<sub>3</sub> could almost totally reversed the hepatotoxicity induced by hepatitis B virus X protein (HBx) (<i>P</i> < 0.001), which were the main causes of HCC in patients. Studies at the cellular levels showed that low-dose Na<sub>2</sub>SeO<sub>3</sub> inhibited the HBx-related hepatotoxicity by blocking ferroptosis, and glutathione peroxidase 4 (GPX4) mediated this regulatory role. Mice model results confirmed that the treatment with Na<sub>2</sub>SeO<sub>3</sub> could mitigated LPS/D-GalN-induced hepatic injury through ferroptosis pathways.</p><p><strong>Conclusion: </strong>Selenium regulated the dual cell death in different HCC stages via different signaling pathways, which could partly explain the anti-HBV and anti-HCC properties of selenium.</p>","PeriodicalId":49326,"journal":{"name":"Analytical Cellular Pathology","volume":null,"pages":null},"PeriodicalIF":2.6000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482541/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Analytical Cellular Pathology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1155/2023/6681065","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Methods: The serum selenium level was determined in 45 patients with HBV-positive HCC (HBV+-HCC group), 45 patients with chronic hepatitis B virus infection (CHB group), and 45 healthy cases (HC group). The sodium selenite (Na2SeO3)-treated HepG2.2.15 cells were used to observe the regulatory role of selenium on HBV replication. D-GalN/erastin-added HL7702 was used to determine the regulatory roles of Na2SeO3 on hepatotoxicity or hepatocyte ferroptosis. The wild-type (WT) C57BL/6 mice and HBx-Tg mice were received lipopolysaccharide (LPS)/D-GalN, together with or without Na2SeO3 administration for indicated period. Following euthanasia, the blood and liver tissue samples were collected, and specific markers were evaluated subsequently.

Results: The serum selenium level was downregulated in patients with HBV-positive HCC (HBV+-HCC group) (57.2 ± 22.5 μg/L vs. 91.8 ± 43.9 μg/L, P < 0.001), and its higher level could provide a better prognosis in these patients. The treatment using Na2SeO3, a selenium donor, at high concentration (5 μM), suppressed the HBV replication by about 50% in HepG2.2.15 cells (P < 0.001), through promoting apoptotic cell death and inhibiting cellular inhibitor of apoptosis proteins (cIAPs). In addition, low-dose (500 nM) Na2SeO3 could almost totally reversed the hepatotoxicity induced by hepatitis B virus X protein (HBx) (P < 0.001), which were the main causes of HCC in patients. Studies at the cellular levels showed that low-dose Na2SeO3 inhibited the HBx-related hepatotoxicity by blocking ferroptosis, and glutathione peroxidase 4 (GPX4) mediated this regulatory role. Mice model results confirmed that the treatment with Na2SeO3 could mitigated LPS/D-GalN-induced hepatic injury through ferroptosis pathways.

Conclusion: Selenium regulated the dual cell death in different HCC stages via different signaling pathways, which could partly explain the anti-HBV and anti-HCC properties of selenium.

Abstract Image

Abstract Image

Abstract Image

硒供体通过细胞凋亡和铁凋亡途径抑制乙型肝炎病毒相关肝毒性。
方法:测定45例HBV阳性HCC患者(HBV+-HCC组)、45例慢性乙型肝炎病毒感染患者(CHB组)和45例健康患者(HC组)血清硒水平。采用亚硒酸钠(Na2SeO3)处理HepG2.2.15细胞,观察硒对HBV复制的调控作用。采用添加D-GalN/erastin的HL7702来测定Na2SeO3对肝毒性或肝细胞铁凋亡的调节作用。野生型(WT) C57BL/6小鼠和HBx-Tg小鼠分别接受脂多糖(LPS)/D-GalN,同时或不同时给予Na2SeO3。安乐死后,采集血液和肝脏组织样本,随后评估特定标志物。结果:HBV阳性HCC患者(HBV+-HCC组)血清硒水平下调(57.2±22.5 μg/L vs. 91.8±43.9 μg/L, P < 0.001),血清硒水平升高可改善预后。高浓度(5 μM)硒供体Na2SeO3通过促进细胞凋亡和抑制细胞凋亡抑制蛋白(cIAPs),抑制HepG2.2.15细胞中HBV复制约50% (P < 0.001)。此外,低剂量(500 nM) Na2SeO3几乎可以完全逆转乙型肝炎病毒X蛋白(HBx)引起的肝毒性(P < 0.001),这是患者HCC的主要原因。细胞水平的研究表明,低剂量Na2SeO3通过阻断铁凋亡抑制hbx相关的肝毒性,而谷胱甘肽过氧化物酶4 (GPX4)介导了这一调节作用。小鼠模型结果证实,Na2SeO3可通过脂多糖/ d - galn诱导的铁下垂途径减轻肝损伤。结论:硒通过不同的信号通路调控肝癌不同分期双细胞死亡,这可以部分解释硒抗hbv和抗HCC的作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Analytical Cellular Pathology
Analytical Cellular Pathology ONCOLOGY-CELL BIOLOGY
CiteScore
4.90
自引率
3.10%
发文量
70
审稿时长
16 weeks
期刊介绍: Analytical Cellular Pathology is a peer-reviewed, Open Access journal that provides a forum for scientists, medical practitioners and pathologists working in the area of cellular pathology. The journal publishes original research articles, review articles, and clinical studies related to cytology, carcinogenesis, cell receptors, biomarkers, diagnostic pathology, immunopathology, and hematology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信